The size of the Global Hematology Market is expected to have a healthy CAGR from 2019 to 2024
The rising number of blood donation camps across the world is a major factor propelling the demand of the hematology market. Increasing incidences of chronic diseases are also driving the growth of the market. The growing geriatric population is additionally accelerating the demand of the market.
However, lack of sufficient knowledge over the utilization of the devices in rural areas is slowly hindering the demand of the market. The high cost of installation and maintenance of the equipment, especially in laboratories is a challenging factor for the market.
Growing prevalence for the point of care testing devices is to set up growth opportunities for the market. Increasing support from the government through investments is greatly influencing the growth of the hematology market. People's interests in cost-effective diagnosis procedures are boosting up the growth of the market.
Recent developments in Hematology Industry:
Market Size Available
2018 – 2024
2019 – 2024
By Product, Application, End-User, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Siemens AG Healthcare, Johnson & Johnson, Beckman Coulter, Inc., Abbott Laboratories, Thermo Fisher Scientific, Roche, HORIBA Ltd., Sysmex Corporation, Bio-Rad Laboratories Inc., Boule Diagnostics AB, Mindray Medical International Limited.
The research report on the Global Hematology Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.
Hematology Market Analysis – By Product:
On the basis of product, Hematology Analysers product type is holding prominent shares of the market. Increasing incidences of road accidents due to which there is a rise in the demand to store blood which can be used in emergency cases is greatly influencing the growth of the market.
Hematology Market Analysis - By Application:
On the basis of application, the Infectious diseases application segment is leading with the highest shares of the market by owing to increasing incidences of various health disorders. Also, the rise in the spending on healthcare centers is making the shares of the market expand in foreseen years.
Hematology Market Analysis - By End-User:
On the basis of End-User, Hospitals end-user category is holding with dominant shares of the market. Growing constructional activities of hospitals due to the increasing flow of patients with varied diseases is accelerating the growth of the market. Rising prevalence for the minimally invasive surgeries to cure the diseases more effectively with available treatment options is ascribed to bolster the demand of the market.
North America is accounted for in leading with dominant shares of the market. The rise in the capital income in both developed and developing countries is the primary attribute lavishing the demand of the market. Also, growing research institutes to develop quality products at an effective price is escalating the growth of the market.
Following North America, Asia pacific is the one leading the highest shares of the market. The increasing population is magnifying the demand of the market. In addition, increasing awareness over the utilization of the latest technology is leveraging the growth of this market in this region. Europe is growing at a faster rate from past years and will continue to have the same growth rate in foreseen years. The replacement of traditional testing devices with modern devices is broadening the demand of the market. The Middle East and Africa are deemed to the inclined growth rate in near future.
List of key market participants profiled:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Hematology Analyzers
5.1.3 Hematology reagents
5.1.4 Flow cytomers
5.1.5 Hematology cell counters
5.1.6 Slide stainers
5.1.7 Coagulation Analyzers
5.1.8 Hematology testing
5.1.12 Y-o-Y Growth Analysis, By Products
5.1.13 Market Attractiveness Analysis, By Products
5.1.17 Market Share Analysis, By Products
5.2.2 Infectious diseases
5.2.4 Cardiovascular diseases
5.2.5 Blood Screening
5.2.8 Autoimmune disorders
5.2.10 Y-o-Y Growth Analysis, By Application
5.2.11 Market Attractiveness Analysis, By Application
5.2.12 Market Share Analysis, By Application
5.3 End users
5.3.4 Diagnostic Laboratories
5.3.5 Research and development centers
5.3.7 Y-o-Y Growth Analysis, By End users
5.3.8 Market Attractiveness Analysis, By End usersd
5.3.9 Market Share Analysis, By End users
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.4 Market Attractiveness Analysis
6.1.5 Market Share Analysis
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Siemens AG Healthcare
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Johnson & Johnson
8.3 Beckman Coulter, Inc.
8.4 Abbott Laboratories
8.5 Thermo Fisher Scientific
8.7 HORIBA Ltd.
8.8 Sysmex Corporation
8.9 Bio-Rad Laboratories Inc.
8.10 Boule Diagnostics AB
8.11 Mindray Medical International Limited
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures